Preparation changes the product

Blood is collected and centrifuged to separate a platelet-rich portion. Devices and protocols can produce different concentrations, white-cell content, volumes, and final preparations.

Autologous does not mean proven or free of risk

Using the patient’s own blood may reduce some product concerns, but injection still carries discomfort, bruising, infection risk, cost, and the possibility of no meaningful benefit.

  • Ask what condition is being treated
  • Review evidence for that use
  • Discuss alternatives

Use indication-specific evidence

Evidence for musculoskeletal, skin, hair, and penile uses is not interchangeable. The consultation should focus on the particular problem and available established care.

Begin with the condition, not the proposed injection

Erection quality, retraction, ejaculation timing, sensation, appearance, and tissue health are different concerns. A responsible assessment includes onset, pattern, medical history, medication, cardiovascular context, examination where appropriate, and established alternatives before an emerging procedure is discussed.

A biological mechanism or early study signal does not establish that a treatment is suitable, predictable, or superior. The target outcome must be named and measured rather than inferred from regenerative or relaxation language.

Read early evidence for what it actually studied

Small studies can help generate questions but may lack adequate controls, blinding, standardized protocols, diverse participants, or long follow-up. A change in a questionnaire, blood-flow measure, flaccid appearance, or laboratory marker is not automatically a meaningful clinical benefit.

Review the sample size, comparison group, eligibility criteria, treatment preparation, dose, outcome definition, duration, adverse-event collection, and conflicts of interest. Evidence from one protocol should not be generalized to every product or technique.

Product, preparation, risk, and follow-up must be specific

Ask what is injected, how it is prepared and sourced, whether the use is authorized or off-label, what complications are plausible, and who provides urgent care. Autologous material or a familiar medicine does not remove uncertainty or procedural risk.

Enhancement Institute uses an assessment-led process and does not promise that PRP, botulinum toxin, or another emerging procedure will be offered. Suitability, alternatives, and follow-up must be determined through an individual clinical assessment.

Questions to resolve before making a decision

Ask what diagnosis or goal is being addressed, which outcomes are realistically measured, what remains uncertain, and which alternatives include observation or no treatment. Request the evidence for the exact product, device, medication, or procedure being proposed rather than evidence borrowed from a related intervention.

Confirm provider qualifications, complete cost, privacy, preparation, material risks, urgent-contact instructions, routine follow-up, and the plan after limited response or dissatisfaction. Bring a current medication list and relevant records, and allow time for questions. Record which clinician will remain responsible if another referral or urgent assessment becomes necessary for safety. Note any claim that feels too certain, incomplete, outdated, or inconsistent with current clinical practice and ask for clarification. This article is general education; it does not diagnose, establish candidacy, or replace individualized advice from the appropriate regulated clinician.

Important

This article is general educational information, not medical advice. Suitability, risks, alternatives, and next steps require an individual consultation with a qualified physician.

Sources and further reading American Academy of Dermatology: Hair-loss diagnosis and treatment European Association of Urology: Management of erectile dysfunction